While injectable forms of weight-loss drugs remain the gold standard for efficacy, according to trial results, both Eli Lilly and Novo Nordisk have leaned into pill formulations
Glucagon-like peptide-1 and its class B G protein-coupled receptors: a long march to therapeutic successes
The brand's FAQ describes both ingredients as "clinically studied compounds." That's a defensible description of the ingredients in isolation and an easy phrase to misread as a claim about the finished product
SRY LabsRetatrutide A severe Jan 2026 identity/quantity failure (0 mg, -100%) is the main concern in SRY Labs' Retatrutide evidence, alongside an early 98.75% purity miss
Patients in the UK seeking weight management support should consult their GP or an NHS specialist obesity service, where NICE-recommended options such as semaglutide (Wegovy) and tirzepatide (Zepbound) are currently available
At 40 weeks, mean body weight changes were 7.5 kg with 10 mg and 8.8 kg with 15 mg doses, compared to 1.6 kg with placebo